JC

James Calloway

Financial Reporter

James Calloway is a financial reporter at StockTi covering corporate earnings, regulatory policy, and market-moving events. A former business journalist with Reuters, James has covered financial markets for over eight years across New York and Washington. He specializes in breaking down earnings reports, SEC filings, and policy decisions that affect publicly traded companies and investor portfolios.

Earnings, Regulation 1,768 articles

Articles by James Calloway

Snap Stock Falls 5% After Q1 Revenue Beat, Cautious Q2 Outlook, and End of Perplexity AI Deal
Earnings

Snap Stock Falls 5% After Q1 Revenue Beat, Cautious Q2 Outlook, and End of Perplexity AI Deal

Snap Inc. reported Q1 revenue up 12% to $1.53B and 483M daily active users, but shares fell 5% after a cautious Q2 outlook and the end of the $400M Perplexity AI deal.

SNAP META
Coherent Stock Dips Despite Strong AI-Driven Q3 Results
Earnings

Coherent Stock Dips Despite Strong AI-Driven Q3 Results

Coherent Corp. shares dropped 6% after hours despite beating Q3 revenue estimates at $1.81B, driven by AI infrastructure demand. Wall Street focused on weak cash flow and margin misses.

COHR CIEN LITE
AppLovin Shares Slide Despite Q1 Beat as Investors Eye Growth Sustainability
Earnings

AppLovin Shares Slide Despite Q1 Beat as Investors Eye Growth Sustainability

AppLovin reported Q1 revenue of $1.84B, up 59% YoY, and net income of $1.21B, more than doubling. Shares dropped 2.3% after hours as investors question long-term growth.

APP
Loblaw Stock Dips 5% as Q1 Revenue Miss Overshadows Profit Growth
Earnings

Loblaw Stock Dips 5% as Q1 Revenue Miss Overshadows Profit Growth

Loblaw reported Q1 revenue of C$14.48B, missing forecasts, sending shares down 5%. Net earnings rose to C$594M, and the company raised its dividend by 10% while approving a new buyback.

L
Celsius Stock Tests Lows as PepsiCo Partnership Faces Earnings Scrutiny
Earnings

Celsius Stock Tests Lows as PepsiCo Partnership Faces Earnings Scrutiny

Celsius Holdings shares trade near a 52-week low before Q1 earnings, with investors focused on PepsiCo partnership execution and portfolio expansion results.

CELH PEP MNST KDP COST
Beyond Meat Tops $1 Ahead of Q1 Results, Nasdaq Compliance in Focus
Earnings

Beyond Meat Tops $1 Ahead of Q1 Results, Nasdaq Compliance in Focus

Beyond Meat shares reclaimed the $1 mark ahead of first-quarter earnings, but Nasdaq compliance pressure remains as the company faces a deadline to boost its stock price.

BYND
Compass Shares Surge 26% on Q1 Profit and Upbeat Q2 Forecast After Anywhere Deal
Earnings

Compass Shares Surge 26% on Q1 Profit and Upbeat Q2 Forecast After Anywhere Deal

Compass Inc. shares surged 26% after reporting a first-quarter profit and issuing a strong second-quarter revenue forecast, boosted by its Anywhere Real Estate acquisition.

COMP
NICE Ltd Shares Slump 23% on Weak Q2 Forecast Despite AI Growth
Earnings

NICE Ltd Shares Slump 23% on Weak Q2 Forecast Despite AI Growth

NICE Ltd shares tumbled 22.9% to $96.35 after Q2 revenue guidance fell short of expectations, despite a Q1 earnings beat and strong AI recurring revenue growth of 66%.

CDW Shares Tumble 19% as Hardware Shift Squeezes Margins Despite Sales Beat
Earnings

CDW Shares Tumble 19% as Hardware Shift Squeezes Margins Despite Sales Beat

CDW shares plunged 19% after Q1 gross margin fell to 21% from 21.6%, even as revenue topped expectations at $5.68 billion. The shift toward lower-margin hardware sales weighed on earnings.

CDW
Joby Aviation Soars 18% on Q1 Revenue Beat, 2026 Air Taxi Plans
Earnings

Joby Aviation Soars 18% on Q1 Revenue Beat, 2026 Air Taxi Plans

Joby Aviation shares jumped 18% after Q1 revenue exceeded expectations and the company reiterated its target for initial passenger flights in 2026, with $2.5 billion in cash to fund certification and factory projects.

JOBY ACHR
Novavax Surges on Pfizer Deal, Beats Q1 Revenue Forecasts
Earnings

Novavax Surges on Pfizer Deal, Beats Q1 Revenue Forecasts

Novavax topped Q1 revenue estimates at $139.5M, driven by a $30M Pfizer payment, offsetting weak COVID vaccine sales. Shares rose 15.6%.

NVAX PFE
One Stop Systems Surges on Q1 Revenue Beat; Memory Supply Risks Emerge
Earnings

One Stop Systems Surges on Q1 Revenue Beat; Memory Supply Risks Emerge

One Stop Systems reported a 55% revenue jump to $8.1 million, beating estimates, but flagged memory supply risks and customer concentration.

OSS